Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News HippoFi Inc ORHB

Healthcare Medical Devices
ORHub Inc formerly known as MemReg, Inc is a player in the software industry. It develops a cloud-based software platform designed to transform the business of surgery into a value-based model. The platform empowers care providers at every stage of the surgical process to collaborate, organize, deliver, measure, and reimburse in one intuitive, easy-to-use program. The company offers surgical... see more

Recent & Breaking News (GREY:ORHB)

Hippofi Welcomes Scott Bauccio as New Head of Sales for Pur Biologics

Accesswire January 23, 2024

HippoFi Ships International Orders and Expects Sales to Exceed $20 Million in the New Year

Accesswire December 11, 2023

HippoFi Continues to Deliver Sales Growth Adding 14 Major Healthcare Facilities

Accesswire December 5, 2023

Dr. Gail Naughton, World-Renowned Authority in the Multibillion-Dollar Regenerative Medicine Market, Joins HippoFi as the Head of Regenerative Therapeutics and Commercialization

Accesswire November 7, 2023

International Sales Win for PUR Biologics

Accesswire October 24, 2023

PUR Biologics Secures Innovative Medical Patent with Strong Financial Upside

Accesswire September 12, 2023

HippoFi Announces Strategic Alliance to Lead Spinal Biologics Innovation

Accesswire September 6, 2023

US Patent Office Issues New Patent to PUR Biologics for Advanced Cartilage Regeneration and Arthritis Solutions

Accesswire August 14, 2023

HippoFi Finalizes an Exclusive Strategic Partnership with International Biomedical Manufacturing Company, BPB Medica

Accesswire August 9, 2023

HippoFi is Finalizing Definitive Agreements to Join Forces with Industry Giant to Revolutionize the Spinal Biologic Market

Accesswire July 25, 2023

HippoFi Anticipates a New Strategic Partnership as the Company Prepares to Launch PURmarrow 360, a Patented Stem Cell Harvesting Device

Accesswire July 25, 2023

HippoFi's PUR Biologics Granted National Approval at the Veterans Health Administration (VHA), the Largest Integrated Healthcare System in the United States

Accesswire June 27, 2023

PUR Biologics Begins Shipment of its Breakthrough Product PURbonedough(TM)

Accesswire May 9, 2023

PUR Biologics Expands Sales Network by 15%, Adding 32 New Distributors

Accesswire April 27, 2023

CORRECTION BY SOURCE: Goldman Small Cap Research Publishes New Research Report on HippoFi, Inc.

Accesswire April 20, 2023

Goldman Small Cap Research Publishes New Research Report on HippoFi, Inc.

Accesswire April 20, 2023

US Patent Office Grants PUR Biologics' Breakthrough Patent for Activating Immune Cells

Accesswire April 19, 2023

PUR Biologics Launches PURfiberXP(TM), a Best-in-Class Cortical Fiber Matrix for Bone Regeneration

Accesswire April 13, 2023

HippoFi Announces Its Return to a Pink Current Information Tier on the OTC Market

Accesswire April 11, 2023

PUR Biologics Announces Launch of PURcore, a bioActive Moldable Synthetic for Spine Surgery

Accesswire April 6, 2023